|
|
|
|
|
Bupropion Hydrochloride |
|
C13H18ClNO•HCl |
|
31677-93-7 |
|
Bupropion is an indirect dopaminergic agonist, developed by GlaxoSmithKline as an antidepressant. It may also have potential in obesity, and post-traumatic stress. A sustained-release formulation (bupropion SR qv) is launched for the treatment of depression and as an aid to smoking cessation. |
|
USP24 |
Industrial field |
cosmetics, pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|